Catalyst Wire Dossier Catalyst Wire Dossier

Nadroparin (Fraxiparine)

nadroparin · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nadroparin (Fraxiparine), covering 2008-11-24 to 2008-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Nadroparin for the Initial Treatment of Pulmonary Thromboembolism [Phase 4]

See pricing